Welcome to our dedicated page for Ormat Tech SEC filings (Ticker: ORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ormat Technologies filings document the regulatory record for a NYSE-listed renewable energy operating company with common shares traded under ORA. Recent Form 8-K reports furnish operating and financial results, non-GAAP reconciliations, and exhibits tied to quarterly earnings releases.
The filing record also covers material definitive agreements and capital-structure disclosures, including indentures for Series A and Series B convertible senior notes due 2031. Proxy materials address shareholder voting matters, board governance, executive compensation, equity awards, and pay-versus-performance disclosures.
ORA — Form 144 notice of proposed sale of restricted common stock. The filing lists 250 shares of Common Stock described as Restricted Stock to be sold by an issuer-related source, with an indicated value of $34,605.70. The filing also shows a prior sale of 577 shares on 05/15/2026 with an indicated value of $75,108.15. A total share count of 61,451,752 shares appears in the excerpt with an associated date of 05/27/2026.
Ormat Technologies director Michal Marom sold shares in an open-market trade. On May 19, 2026, Marom sold 3,080 shares of Ormat Technologies common stock in an open-market transaction at an average price of $130.975 per share. After the sale, Marom directly holds 1,766 shares of the company’s common stock.
Ormat Technologies director David Granot sold 3,519 shares of Common Stock in two open‑market transactions. He sold 1,753 shares at $132.70 per share on May 20, 2026, and 1,766 shares at $134.425 per share on May 21, 2026. These sales reduced his directly held Ormat shares to zero, and the filing shows no remaining derivative positions.
ORMAT TECHNOLOGIES, INC. director David Granot reported a combination of equity award activity and share sales. He exercised 1,315 Stock Appreciation Rights at an exercise price of $67.54 per share when the market price was $73.84, which generated 112 net shares after 1,203 shares were disposed of to the issuer for tax withholding related to the exercise. On the same date, he then sold a total of 950 shares of common stock in multiple open-market transactions at prices between $72.99 and $73.84. Following these transactions, he directly owned 2,825 shares of Ormat common stock. This Form 4 amendment corrects an earlier filing that had omitted the SAR exercise and tax-related disposition and had misclassified 112 net shares as an open-market sale.
ORA filed a Rule 144 notice reporting a proposed sale of restricted common stock. The filing lists 1,766 shares of Common Stock to be sold as restricted stock, with $237,394.55 shown on the cover line and Morgan Stanley Smith Barney LLC named as the broker. The filing also records a prior sale of 1,753 shares on 05/20/2026 for $232,623.10.
ORA submitted a Form 144 notice reporting proposed sales of Common Stock through Morgan Stanley Smith Barney LLC. The filing lists three restricted-share lots dated 06/02/2023 (1,461 shares), 05/09/2024 (761 shares), and 05/08/2025 (858 shares).
The Form 144 identifies the broker-dealer and characterizes the securities as restricted stock; the notice documents intended sales rather than completed open-market trades.
ORMAT TECHNOLOGIES, INC. executive vice president Benyosef Ofer reported a combination of stock option–style exercises and share sales in company common stock. He exercised 1,101 Stock Appreciation Rights with an exercise price of $71.15 per share, which resulted in 499 shares of common stock being issued and 602 shares effectively returned to the issuer as part of the SAR settlement mechanics. On the same date, he sold 9,429 shares of common stock in open-market transactions at $131.02 per share under a pre-arranged Rule 10b5-1 trading plan, and after these transactions he no longer directly holds Ormat common stock.
Ormat Technologies director Stanley Stern sold shares in a routine open-market transaction. On May 15, 2026, he sold 577 shares of Ormat Technologies common stock at a price of $130.17 per share. After this sale, he directly holds 6,050 common shares, indicating he retains a substantial position despite the relatively small disposition.
Ormat Technologies’ Chief Financial Officer Assi Ginzburg reported a combination of option exercises and share sales in Common Stock. On May 14, 2026, he exercised 5,502 Stock Appreciation Rights at an exercise price of $71.15 per share, converting them into Common Stock. The filing states that only 2,559 shares of Common Stock were issued from this SAR exercise, based on the difference between the market value of $133.118 and the exercise price. The CFO then disposed of shares through an issuer-related transaction and open-market sales totaling 17,776 shares at weighted average prices of $133.118 and $135.019 per share, across price ranges from $133.02 to $135.265. Following these transactions, he directly holds 1,970 shares of Ormat Technologies Common Stock.